ClinicalTrials.Veeva

Menu

Fluid Management Strategies on Blood Loss in Liver Transplantation

National Taiwan University logo

National Taiwan University

Status

Enrolling

Conditions

Liver Transplant

Treatments

Other: Liberal group
Other: restrictive group

Study type

Interventional

Funder types

Other

Identifiers

NCT06215404
202308015MINC

Details and patient eligibility

About

During liver transplantation, due to the complexity of the operation and abnormal coagulation function, there may be a large amount of bleeding and corresponding blood transfusion. Excessive blood transfusion will increase pulmonary complications and affect the prognosis. Infusion management to reduce bleeding is a very important issue in liver transplant surgery. Restrictive infusion management can effectively reduce the amount of bleeding in liver transplantation, but it remains unclear whether it will cause sequelae in other major organs.

The investigators plan to study different infusion goals and strategies in liver transplant surgery using a randomized group model, using the PiCCO (Pulse Contour Cardiac Output) cardiopulmonary volume monitor, and setting the stroke volume variation (SVV) as the macroscopic circulation.The purpose of this study was to divide it into restrictive and liberal groups to explore the impact on liver transplantation bleeding volume and inflammatory response as well as postoperative lung and renal function, and to collect statistics on clinical care and postoperative sequelae (pulmonary liver, renal function impairment, etc.) in order to develop the most appropriate infusion management strategy in liver transplantation.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • end stage liver disease
  • age between 18y/o to 75 y/o
  • expected to recieve to receive liver transplantation

Exclusion criteria

  • arrythmia

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Liberal group
Active Comparator group
Description:
stroke volume variation \< 10%
Treatment:
Other: Liberal group
restrictive group
Experimental group
Description:
stroke volume variation \< 18%
Treatment:
Other: restrictive group

Trial contacts and locations

1

Loading...

Central trial contact

Kuang-Cheng Chan, M.D.,PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems